Work

Baton-Crc: a Phase 2 Randomized Trial Comparing Tivozanib (Tivo) + Mfolfox6 with Bevacizumab (Bev) + Mfolfox6 in Stage Iv Metastatic Colorectal Cancer (Mcrc)

Year: 2014

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdu333.36

Authors: A. Benson, J.A. Bridgewater, I. Kiss, F. Eskens, J. Chen, C. Sasse, S. Vossen, C. van Sant, H. Ball, A. Keating, A. Krisvoshik

Institutions: Robert H. Lurie Comprehensive Cancer Center of Northwestern University, University College London, Masaryk Memorial Cancer Institute, Erasmus MC Cancer Institute, Astellas Pharma (United States)

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2467590014

FWCI: 0.481

Cites:

Cited by: 3

Related to: 10